🚀 VC round data is live in beta, check it out!

Atlas Arteria Valuation Multiples

Discover revenue and EBITDA valuation multiples for Atlas Arteria and similar public comparables like Parkin, Zhejiang Expressway, Pinfra, Granite Construction and more.

Atlas Arteria Overview

About Atlas Arteria

Atlas Arteria is a global toll-road investor created out of the reorganization of Macquarie Infrastructure Group in 2010. The firm's main asset is a 30.82% stake in Autoroutes Paris-Rhin-Rhone, or APRR. APRR owns concessions to toll more than 2,300 kilometers of motorways in eastern France, most ending late 2035. The firm also wholly owns the Dulles Greenway and 66.67% of the Chicago Skyway, both in the US.


Founded

2009

HQ

Australia

Employees

3.3K

Financials (LTM)

Revenue: $118M
EBITDA: $38M

EV

$6B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Atlas Arteria Financials

Atlas Arteria reported last 12-month revenue of $118M and EBITDA of $38M.

In the same LTM period, Atlas Arteria generated $38M in EBITDA and $162M in net income.

Revenue (LTM)


Atlas Arteria P&L

In the most recent fiscal year, Atlas Arteria reported revenue of $114M and EBITDA of $251M.

Atlas Arteria expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Atlas Arteria forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$118MXXX$114MXXXXXXXXX
Gross Profit—XXX$96MXXXXXXXXX
Gross Margin—XXX84%XXXXXXXXX
EBITDA$38MXXX$251MXXXXXXXXX
EBITDA Margin32%XXX221%XXXXXXXXX
EBIT Margin(9%)XXX(11%)XXXXXXXXX
Net Profit$162MXXX$181MXXXXXXXXX
Net Margin138%XXX160%XXXXXXXXX
Net Debt——$1BXXXXXXXXX

Financial data powered by Morningstar, Inc.

Atlas Arteria Stock Performance

Atlas Arteria has current market cap of $5B, and enterprise value of $6B.

Market Cap Evolution


Atlas Arteria's stock price is $3.35.

See Atlas Arteria trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$6B$5B-1.2%XXXXXXXXX$0.13

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Atlas Arteria Valuation Multiples

Atlas Arteria trades at 49.8x EV/Revenue multiple, and 156.2x EV/EBITDA.

See valuation multiples for Atlas Arteria and 15K+ public comps

EV / Revenue (LTM)


Atlas Arteria Financial Valuation Multiples

As of March 15, 2026, Atlas Arteria has market cap of $5B and EV of $6B.

Equity research analysts estimate Atlas Arteria's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Atlas Arteria has a P/E ratio of 29.9x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$5BXXX$5BXXXXXXXXX
EV (current)$6BXXX$6BXXXXXXXXX
EV/Revenue49.8xXXX51.8xXXXXXXXXX
EV/EBITDA156.2xXXX23.4xXXXXXXXXX
EV/EBIT(579.1x)XXX(486.6x)XXXXXXXXX
EV/Gross Profit—XXX61.5xXXXXXXXXX
P/E29.9xXXX26.8xXXXXXXXXX
EV/FCF19.9xXXX20.7xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Atlas Arteria Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Atlas Arteria Margins & Growth Rates

Atlas Arteria's revenue in the last 12 month grew by 16%.

Atlas Arteria's revenue per employee in the last FY averaged $0.0M.

Atlas Arteria's rule of 40 is 48% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Atlas Arteria's rule of X is 72% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Atlas Arteria and other 15K+ public comps

Atlas Arteria Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth16%XXX20%XXXXXXXXX
EBITDA Margin32%XXX221%XXXXXXXXX
EBITDA Growth(25%)XXX(89%)XXXXXXXXX
Rule of 40—XXX48%XXXXXXXXX
Bessemer Rule of X—XXX72%XXXXXXXXX
Revenue per Employee—XXX$0.0MXXXXXXXXX
G&A Expenses to Revenue—XXX24%XXXXXXXXX
Opex to Revenue—XXX99%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Atlas Arteria Public Comps

See public comps and valuation multiples for other Road Infrastructure comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
ParkinXXXXXXXXXXXXXXXXXX
Zhejiang ExpresswayXXXXXXXXXXXXXXXXXX
PinfraXXXXXXXXXXXXXXXXXX
Granite ConstructionXXXXXXXXXXXXXXXXXX
Guangdong ExpresswayXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Atlas Arteria M&A Activity

Atlas Arteria acquired XXX companies to date.

Last acquisition by Atlas Arteria was on XXXXXXXX, XXXXX. Atlas Arteria acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Atlas Arteria

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Atlas Arteria Investment Activity

Atlas Arteria invested in XXX companies to date.

Atlas Arteria made its latest investment on XXXXXXXX, XXXXX. Atlas Arteria invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Atlas Arteria

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Atlas Arteria

When was Atlas Arteria founded?Atlas Arteria was founded in 2009.
Where is Atlas Arteria headquartered?Atlas Arteria is headquartered in Australia.
How many employees does Atlas Arteria have?As of today, Atlas Arteria has over 3K employees.
Who is the CEO of Atlas Arteria?Atlas Arteria's CEO is Hugh Wehby.
Is Atlas Arteria publicly listed?Yes, Atlas Arteria is a public company listed on Australian Securities Exchange.
What is the stock symbol of Atlas Arteria?Atlas Arteria trades under ALX ticker.
When did Atlas Arteria go public?Atlas Arteria went public in 2010.
Who are competitors of Atlas Arteria?Atlas Arteria main competitors are Parkin, Zhejiang Expressway, Pinfra, Granite Construction.
What is the current market cap of Atlas Arteria?Atlas Arteria's current market cap is $5B.
What is the current revenue of Atlas Arteria?Atlas Arteria's last 12 months revenue is $118M.
What is the current revenue growth of Atlas Arteria?Atlas Arteria revenue growth (NTM/LTM) is 16%.
What is the current EV/Revenue multiple of Atlas Arteria?Current revenue multiple of Atlas Arteria is 49.8x.
Is Atlas Arteria profitable?Yes, Atlas Arteria is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Atlas Arteria?Atlas Arteria's last 12 months EBITDA is $38M.
What is Atlas Arteria's EBITDA margin?Atlas Arteria's last 12 months EBITDA margin is 32%.
What is the current EV/EBITDA multiple of Atlas Arteria?Current EBITDA multiple of Atlas Arteria is 156.2x.
What is the current FCF of Atlas Arteria?Atlas Arteria's last 12 months FCF is $295M.
What is Atlas Arteria's FCF margin?Atlas Arteria's last 12 months FCF margin is 250%.
What is the current EV/FCF multiple of Atlas Arteria?Current FCF multiple of Atlas Arteria is 19.9x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial